19 Companies Pioneering AI Foundation Models in Pharma and Biotech
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
#AI in Drug Discovery
Formation Bio Secures $372 Million Series D Funding for AI-Driven Drug Development
Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional …
QuantumPharm (XtalPi) Begins Trading on Hong Kong Stock Exchange
QuantumPharm, operating as XtalPi, an AI-driven drug research company from China, commenced trading on the Hong Kong Stock Exchange on …
Lantern Pharma Receives Japanese Patent for Oncology Drug Candidate LP-284
Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted …
Envisagenics Secures $25 Million Series B Funding to Advance RNA Splicing Therapeutics
Envisagenics, an AI-enabled biotechnology firm specializing in RNA splicing therapeutics, has announced the completion of its Series B funding round. …
Paige Introduces Multi-Modal AI for Enhanced Precision Oncology and Drug Discovery
Paige, a provider of digital pathology solutions and AI applications, has launched a new service line leveraging its Foundation Models. …
DeepCure Unveils AI-Driven Chemical Synthesis Platform
DeepCure, a company specializing in AI-driven therapeutic discovery, has introduced a development in chemical synthesis with its Inspired Chemistry™ platform. …
LabGenius Secures £35 Million to Enhance ML-Driven Antibody Discovery
LabGenius, a leading drug discovery company leveraging machine learning (ML) to discover novel therapeutic antibodies, has successfully completed a £35 …
Insilico Medicine Initiates Phase I Clinical Trial for Novel QPCTL Inhibitor
Insilico Medicine, a biotechnology company specializing in generative artificial intelligence, has begun dosing patients in the first clinical trial for …
Sartorius and NVIDIA to Develop AI Models for Stem Cell-Derived Organoids, Reducing Animal Testing in Drug Discovery
Sartorius, a leader in life sciences and bioprocessing, is expanding its collaboration with NVIDIA to enhance the development of innovative …
Nabla Bio Advances Generative Protein Design with $26M Series A Funding
Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, …
Recursion Unveils BioHive-2, Fastest Pharma-Owned Supercomputer
Recursion Pharmaceuticals has achieved a significant milestone by completing BioHive-2, reportedly the fastest supercomputer to be wholly owned and operated …